Total Payments
$7,690
2024 Payments
$1,174
Companies
45
Transactions
442
Medicare Patients
2,838
Medicare Billing
$439,261
Payment Breakdown by Category
Food & Beverage$7,540 (98.0%)
Education$149.99 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,540 | 440 | 98.0% |
| Education | $149.99 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,751 | 190 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $618.14 | 33 | $0 (2024) |
| Insmed, Inc. | $602.86 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $340.21 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $304.51 | 13 | $0 (2024) |
| Electromed, Inc. | $235.23 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $230.92 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $223.92 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $209.65 | 11 | $0 (2023) |
| Advanced Respiratory, Inc | $173.62 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,174 | 63 | GlaxoSmithKline, LLC. ($266.88) |
| 2023 | $1,474 | 68 | GlaxoSmithKline, LLC. ($361.69) |
| 2022 | $990.43 | 55 | GlaxoSmithKline, LLC. ($284.41) |
| 2021 | $892.34 | 53 | GlaxoSmithKline, LLC. ($218.65) |
| 2020 | $616.09 | 38 | GlaxoSmithKline, LLC. ($294.23) |
| 2019 | $754.48 | 49 | GlaxoSmithKline, LLC. ($314.31) |
| 2018 | $797.08 | 49 | GlaxoSmithKline, LLC. ($431.07) |
| 2017 | $991.54 | 67 | GlaxoSmithKline, LLC. ($579.68) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Airway Clearance Device | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Airway Clearance Device | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Airway Clearance Device | ||||||
| 09/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Immunology | ||||||
| 09/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: HFCWO | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 648 | 1,125 | $867,464 | $101,303 |
| 2022 | 14 | 693 | 1,376 | $965,094 | $109,813 |
| 2021 | 17 | 730 | 1,375 | $837,207 | $107,970 |
| 2020 | 17 | 767 | 1,560 | $409,942 | $120,176 |
Total Patients
2,838
Total Services
5,436
Medicare Billing
$439,261
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 149 | 374 | $268,532 | $33,641 | 12.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 66 | 143 | $219,362 | $23,701 | 10.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 122 | 273 | $136,500 | $16,859 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 101 | $69,993 | $9,494 | 13.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 66 | 66 | $91,674 | $8,308 | 9.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $26,544 | $2,852 | 10.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $20,600 | $2,798 | 13.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 26 | 26 | $10,920 | $1,139 | 10.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 26 | 26 | $10,166 | $1,093 | 10.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 30 | 30 | $8,370 | $897.30 | 10.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 24 | 25 | $4,800 | $520.00 | 10.8% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 13 | 13 | $3.25 | $0.32 | 9.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 174 | 434 | $312,213 | $34,256 | 11.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 129 | 410 | $205,175 | $22,758 | 11.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 112 | $172,882 | $18,977 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 116 | $78,900 | $10,602 | 13.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 57 | $79,224 | $8,698 | 11.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $24,681 | $3,217 | 13.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 19 | $19,570 | $2,701 | 13.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 11 | 62 | $14,403 | $2,301 | 16.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $18,960 | $2,110 | 11.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 27 | 27 | $11,241 | $1,062 | 9.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 26 | 26 | $10,116 | $949.98 | 9.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 21 | 21 | $5,188 | $885.77 | 17.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 24 | 24 | $6,850 | $705.91 | 10.3% |
About Dr. Christopher Blewett, M.D
Dr. Christopher Blewett, M.D is a Pulmonary Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255357679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Blewett, M.D has received a total of $7,690 in payments from pharmaceutical and medical device companies, with $1,174 received in 2024. These payments were reported across 442 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,540).
As a Medicare-enrolled provider, Blewett has provided services to 2,838 Medicare beneficiaries, totaling 5,436 services with total Medicare billing of $439,261. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Plano, TX
- Active Since 07/15/2006
- Last Updated 07/05/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1255357679
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,234
- ANORO (Drug) $611.62
- Arikayce (Drug) $602.86
- NUCALA (Biological) $381.12
- BREO (Drug) $347.96
- ACTHAR (Biological) $304.51
- DUPIXENT (Biological) $245.90
- SMARTVEST (Device) $235.23
- XARELTO (Drug) $230.92
- OFEV (Drug) $227.65
- AIRSUPRA (Drug) $218.31
- GLASSIA (Biological) $176.08
- The Vest System Model 105 Home Care (Device) $173.62
- Yupelri (Drug) $167.73
- XOLAIR (Biological) $165.56
- ANORO ELLIPTA (Drug) $150.37
- SYMBICORT (Drug) $130.64
- FASENRA (Biological) $128.91
- Hillrom - Vest System Model 105 Home Care (Device) $125.18
- Prolastin-C Liquid (Biological) $113.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Plano
Steven Davidoff, Md, MD
Pulmonary Disease — Payments: $360,587
Pulmonary Disease $360,587
James Wilson, Md, MD
Pulmonary Disease — Payments: $56,034
Pulmonary Disease $56,034
Dr. Tayler Long, M.d, M.D
Pulmonary Disease — Payments: $15,358
Pulmonary Disease $15,358
Dr. Tameem Al-Aqtash, M.d, M.D
Pulmonary Disease — Payments: $9,379
Pulmonary Disease $9,379
Dr. Mythili Venkataraman, Md, MD
Pulmonary Disease — Payments: $7,119
Pulmonary Disease $7,119
Dr. John Hughes, M.d, M.D
Pulmonary Disease — Payments: $3,123
Pulmonary Disease $3,123